N/A
N=39
Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use
HIV/AIDS · Methamphetamine Abuse · Depression
Bottom Line
View on ClinicalTrials.gov: NCT03864653 ↗Enrolled (actual)
39
Serious AEs
5.1%
Results posted
Sep 2020
Primary outcome: Primary: Depression Symptoms Over Time — -0.062 Units on a Scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MoodGym (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- Male
- Sponsor
- Friends Research Institute, Inc.
- Primary completion
- Mar 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Depression Symptoms Over Time |
-0.062 | — |
| PRIMARY HIV-Related Medication Adherence |
4.78 | — |
Summary
This study is a single-arm, non-randomized pilot study. Eligible participants are newly enrolled participants in an outpatient methamphetamine treatment program, and study activities will take place contemporaneously with participation in the service program. During the first two weeks of the treatment program, participants will be offered the chance to enroll in a low-intensity, internet-based depression intervention called MoodGym. Participants that agree to enroll will be offered the chance to attend up to seven MoodGym sessions at the same time they undergo outpatient methamphetamine treatment. It is hypothesized that sexual risk outcomes, as well as medication adherence (e.g., PrEP/PEP; ART) outcomes will be optimized for participants who enroll to receive the MoodGym intervention content.
Eligibility Criteria
Inclusion Criteria
- Currently enrolled within the "Getting Off" (AKA, "Friends Getting Off") outpatient methamphetamine treatment program at Friends Community Center, Los Angeles, CA, USA.
- and; within two weeks of initial enrollment into the "Getting Off" program.
Exclusion Criteria
- Not currently enrolled within the "Getting Off" program.
- or; more than two weeks post-enrollment in the "Getting Off" program.
Data sourced from ClinicalTrials.gov (NCT03864653). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.